Showing results (2541-2550 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|February 25, 2016
Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysisErwin Ista, Ben van der Hoven, René F Kornelisse, et al.
The Lancet. Infectious Diseases|December 4, 2014
The future role of CD4 cell count for monitoring antiretroviral therapyNathan Ford, Graeme Meintjes, Anton Pozniak, et al.
The Lancet. Infectious Diseases|August 17, 2015
Clinical value of whole-genome sequencing of Mycobacterium tuberculosisHoward E Takiff, Oscar Feo
The Lancet. Infectious Diseases|November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyAnthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
The Lancet. Infectious Diseases|October 31, 2015
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulationAnthony D Harries, Stephen D Lawn, Amitabh B Suthar, et al.
The Lancet. Infectious Diseases|November 13, 2015
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trialIvan Fan-Ngai Hung, Anna Jinxia Zhang, Kelvin Kai-Wang To, et al.
The Lancet. Infectious Diseases|September 6, 2014
Surveillance for emerging respiratory virusesJaffar A Al-Tawfiq, Alimuddin Zumla, Philippe Gautret, et al.
The Lancet. Infectious Diseases|September 6, 2014
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections--needs, advances, and future prospectsAlimuddin Zumla, Jaffar A Al-Tawfiq, Virve I Enne, et al.
The Lancet. Infectious Diseases|September 6, 2014
Emerging viral respiratory tract infections--environmental risk factors and transmissionPhilippe Gautret, Gregory C Gray, Remi N Charrel, et al.
Pageof 270